Inhibitors to Von Willebrand Factor in Type 3 Von Willebrand Disease (VWD)

Hassan M Yaish, Robert D Christensen, Jessica Meznarich, George M Rodgers, Richard S Lemons and Walid K Salah
Additional contact information
Richard S Lemons: University of Utah
Walid K Salah: Duke University

Biomedical Journal of Scientific & Technical Research, 2017, vol. 1, issue 3, 552-555

Abstract: Type 3 VWD is the least common and most severe among the three types of VWD. The incidence was estimated at 5-3/million and the severity is thought to be similar to mild or moderate hemophilia A...

Keywords: Biomedical Sciences; Biomedical Research; Technical Research; VWD type 3; Inhibitors; re-FVIII; Bethesda units (search for similar items in EconPapers)
Date: 2017
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.000242.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.000242.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:1:y:2017:i:3:p:552-555

DOI: 10.26717/BJSTR.2017.01.000242

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().